Rosiglitazone transiently disturbs calcium homeostasis in monocytic cells

Biochemical and Biophysical Research Communications

Volumn 366, Issue 1, 2008, Pages 149-155

  Caddy, J ^a   Singh, N ^a   Atkin, L ^a   Ahluwalia, M ^a   Roberts, A ^b   Lang, D ^b   Thomas, A W ^a   Webb, R ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anti hyperglycaemic effects; Intracellular Ca2+; Monocyte; PPAR ; Rosiglitazone; SERCA2b

Indexed keywords

LUCIFERASE; MESSENGER RNA; ROSIGLITAZONE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2B; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM HOMEOSTASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IC 50; MONOCYTE; PRIORITY JOURNAL; REPORTER GENE; UPREGULATION;

CALCIUM; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMEOSTASIS; HUMANS; MONOCYTES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THIAZOLIDINEDIONES;

EID: 37349124209     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.095     Document Type: Article

References (25)

1. Advani A., Marshall S.M., and Thomas T.H. Impaired neutrophil store-mediated calcium entry in Type 2 diabetes. Eur. J. Clin. Invest. 34 (2004) 43-49
2. Belke D.D., Swanson E.A., and Dillmann W.H. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53 (2004) 3201-3208
3. 2+-ATPase. Diabetes 53 (2004) 463-473
4. Singh N., Webb R., Adams R., Evans S.A., AlMosawi A., Evans M., Roberts A.W., and Thomas A.W. The PPAR-γ activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium. Biochem. Biophys. Res. Commun. 333 (2005) 455-462
5. 2+ pump expressed in brain, kidney, and stomach is encoded by an alternative transcript of the slow-twitch muscle sarcoplasmic reticulum Ca-ATPase gene. J. Biol. Chem. 263 (1988) 15032-15040
6. Clark J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., and Dillmann W.H. Diabetes and the accompanying hyperglycaemia impairs cardiomyocyte cycling through increased nuclear O-GlycNAcylation. J. Biol. Chem. 278 (2003) 44230-44237
7. Zhong Y., Ahmed S., Grupp I.L., and Matlib M.A. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1137-H1147
8. Smith S.A. Central role of the adipocyte in the insulin-sensitizing and cardiovascular risk modifying actions of the thiazolidinediones. Biochimie 85 (2003) 1219-1230
9. Hetzel J., Balletshoffer B., Rittig K., Walcher D., Kratzer W., Hombach V., Haring H.-U., Koenig W., and Marx N. Rapid effects of Rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler. Thromb. Vacs. Biol. 25 (2005) 1804-1809
10. Nissen S.E., and Wolski K. Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Eng. J. Med. 356 (2007) 2457-2471
11. S. Singh, Y.K. Loke, C.D. Furberg, Thiazolidinediones and Heart Failure: A Teleo-Analysis, Diabetes Care [epub ahead of print].
12. Shah R.D., Gonzales F., Golez E., Augustin D., Caudillo S., Abbot A., Morello J., McDonough P.M., Paolini P.J., and Shubeita H.E. The antidiabetic agent Rosiglitazone upregulates SERCA2 and enhances TNF-α- and LPS-induced NF-κβ-dependent transcription and TNF-α-induced IL-6 secretion in ventricular myocytes. Cell Physiol. Biochem. 15 (2004) 41-50
13. 2+-ATPase expressed in COS-1 cells. Proc. Natl. Acad. Sci. USA 85 (1988) 3314-3318
14. Elsner J., Norgauer J., Dobos G.J., Emmendörffer A., Schöpf E., Kapp A., and Roesler J. Flow cytometry reveals different lag times in rapid cytoplasmic calcium elevations in human neutrophils in response to N-formyl peptide. J. Cell Physiol. 157 (1993) 637-643
15. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 275 (2000) 977-982
16. 2 and other ions in solution, calculation of the true concentrations of species present in mixtures of associating ions. Biochem. J. 159 (1976) 1-5
17. Eckstein-Ludwig U., Webb R.J., van Goethem I.D., East J.M., Lee A.G., Kimura M., O'Neill P.M., Bray P.G., Ward S.A., and Krishna S. Artemisins target the SERCA of Plasmodium falciparum. Nature 424 (2003) 957-961
18. Perez A., Thuillard J.L., Bentzen C.L., and Niessor E.J. Expression of nuclear receptors and apo E secretion during the differentiation of monocytic THP-1 cells into macrophages. Cell Biol. Toxicol. 19 (2003) 95-105
19. Huang W.C., Chio C.C., Chi K.H., Wu H.M., and Lin W.W. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Exp. Cell Res. 277 (2002) 192-200
20. Engelman J.A., Lisanti M.P., and Scherer P.E. Specific inhibitors of p38 MAPK block 3T3-L1 adipogenesis. J. Biol. Chem. 273 (1998) 32111-32120
21. 2+] in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 280 (2001) 843-851
22. Niemi M., Backman J.T., Granfors M., Laitila J., Neuvonen M., and Neuvonen P.J. Gemfibrozil considerably increases the plasma concentrations of Rosiglitazone. Diabetologia 46 (2003) 1319-1323
23. Home P.D., Pocock S.J., Beck-Nielsen H., Gomis R., Hanefeld M., Jones N.P., Komajda M., and McMurray J.J. RECORD Study Group. N. Eng. J. Med. 357 (2007) 28-38
24. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-206
25. J Berridge M., and Galione A. Cytosolic calcium oscillators. FASEB J. 2 (1988) 3074-3082